Better Survival in Kidney Cancer After Stopping Therapy for Immune-Related AEs

(MedPage Today) — DENVER — Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had a trend toward better survival and longer time to treatment failure, according to long-term follow…

Source link : https://www.medpagetoday.com/meetingcoverage/ikcs/118606

Author :

Publish date : 2025-11-19 20:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Better Survival in Kidney Cancer After Stopping Therapy for Immune-Related AEs

We’ve found an unexpected structure in the solar system’s Kuiper belt

Second Anti-HER2 TKI Approved for NSCLC

Related Posts

‘People Are Taking a Sledgehammer to Patients’: What We Heard This Week

Precision or Collateral Damage? Oncology’s F-16 Moment

Regular Physical Activity Thwarts Fatigue, Boosts QoL in Colorectal Cancer

The Berkshire mum looking to encourage others into rugby

Drinking Coffee May Help Improve Heart Health, Lower Diabetes Risk

What Do the New Dietary Guidelines Emphasize?

‘People Are Taking a Sledgehammer to Patients’: What We Heard This Week

Precision or Collateral Damage? Oncology’s F-16 Moment

Regular Physical Activity Thwarts Fatigue, Boosts QoL in Colorectal Cancer

The Berkshire mum looking to encourage others into rugby

Drinking Coffee May Help Improve Heart Health, Lower Diabetes Risk

What Do the New Dietary Guidelines Emphasize?

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

Global Pain Levels; Tertiary Patents on FDA-Approved Drugs

Categories

Archives